"Serious and Immediate Shortage of Hysone (Hydrocortisone) Tablets in Australia"
From: Ivone Johnson
Sent: Tuesday, November 06, 2007 9:36 AM
Subject: "Serious and immediate shortage of Hysone (hydrocortisone) tablets in Australia"
HYSONE™ SUPPLY IN AUSTRALIA
Alphapharm are the sole suppliers of hydrocortisone tablets in Australia. These tablets are sold as HYSONE 4mg or 20mg tablets.
As you may be aware, many pharmacies are currently out of stock of HYSONE tablets. This problem has arisen due to the discontinuation of the low moisture starch sourced for use in the production of HYSONE. As a result, many patients may not be unable to have their prescriptions dispensed over the coming weeks.
We sincerely apologise for this unavoidable situation.
Whilst our manufacturing team continues to analyse acceptable alternative formulations, we are not yet in a position to recommence commercial manufacture although we believe that we may be in a position to do so by mid-late November.
In the meantime, we are pursuing the following strategies to ensure that patients who are short of HYSONE tablets can continue to receive essential supply:
1. We have a very small reserve stock of 20mg tablets, and a slightly larger reserve of 4mg tablets, which we are distributing on an individual patient basis following discussions with the prescriber. We would appreciate the assistance of members of the Endocrine Society in working with us to ensure that only patients genuinely short of tablets, and likely to run out before mid November, receive this reserve stock.
2. We are currently arranging for the importation of hydrocortisone 20mg tablets from the United Kingdom. Pending regulatory clearance we anticipate these tablets will be available for supply towards the middle of November.
3. We have submitted a reformulated 4mg HYSONE tablet for registration by the TGA. We are hopeful of a positive response from the TGA evaluators shortly.
We suggest that reserve stock is only supplied on the advise of either the endocrinologist or general practitioner managing the patient, after contacting Alphapharm Medical Affairs on 02 9298 3965.
Greg Pearce B.Pharm, Dip Hosp Pharm, PhD
Alphapharm Pty Ltd
ESA Council provides
the following advice to General Practitioners and other prescribers:
Seminar Meeting 9-11th May 2008
Clinical Weekend 22-24th August 2008
Annual Scientific Meeting 25-28 August 2008
This Page Refreshed: Saturday, 12. April 2008
This Website Created: Tuesday, 01, August, 2006